Stifel Financial Corp (SF) 34.79 $SF KBW Announces Index

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Stifel Financial Corp (SF) 34.79 $SF

KBW Announces Index Rebalancing for Second-Quarter 2016
BusinessWire - Fri Jun 10, 8:00PM CDT
Keefe, Bruyette & Woods, Inc., a full-service, boutique investment bank and broker-dealer that specializes in the financial services sector, and a wholly owned subsidiary of Stifel Financial Corp. (NYSE:SF), announces the upcoming index rebalancing for second quarter of 2016.
SF: 34.79 (-0.65), AGNC: 18.70 (-0.19)

Stifel and KBW Combine for No. 1 Ranking in 2016 Thomson Reuters Starmine Analyst Awards
Marketwire Canada - Tue May 24, 12:15PM CDT
ST. LOUIS, MO--(Marketwired - May 24, 2016) - Stifel Financial Corp. (NYSE: SF) today announced that its Stifel, Nicolaus & Company, Incorporated ("Stifel" and Keefe, Bruyette & Woods ("KBW" subsidiaries combined to win 18 awards in the 2016 Thomson Reuters StarMine Analyst Awards, ranking the firm tied for first in number of awards won among 167 qualifying U.S. firms. With more than 1,400 companies under coverage in the U.S., Stifel also ranks as the overall largest provider of equity research and as the largest provider of small- and mid-cap coverage.
SF: 34.79 (-0.65)

How Valuable are These Investment Brokerage Stocks? - LPL Financial Holdings, BGC Partners, Stifel Financial, and Greenhill and Co.
PR Newswire - Wed May 18, 7:50AM CDT
Ahead of the today's trading session, ActiveWallSt.com shifts investors' attention on these four U.S. Investment Brokerage equities: LPL Financial Holdings Inc. (NASDAQ: LPLA), BGC Partners Inc. (NASDAQ: BGCP), Stifel Financial Corp. (NYSE: SF), and Greenhill & Co. Inc. (NYSE: GHL). Register now on activate the alerts for these stocks at:
SF: 34.79 (-0.65), GHL: 19.48 (-0.02), LPLA: 24.60 (-0.15), BGCP: 8.98 (+0.01)

Stifel Financial (SF) Q1 Earnings Beat on High Revenues
Zacks Equity Research - Zacks Investment Research - Tue May 10, 7:58AM CDT
Stifel Financial Corp. (SF) reported first-quarter 2016 net income of 57 cents per share from continuing operations, beating the Zacks Consensus Estimate of 52 cents. However, the figure was below the prior-year figure of 65 cents.
SF: 34.79 (-0.65), RJF: 52.68 (-0.18), EFSC: 27.35 (-0.21), LPLA: 24.60 (-0.15)

Stifel posts 1Q profit
Automated Insights - Mon May 09, 3:05PM CDT
ST. LOUIS (AP) _ Stifel Financial Corp. (SF) on Monday reported first-quarter net income of $27.1 million.
SF: 34.79 (-0.65)

Stifel Reports First Quarter 2016 Financial Results
Marketwire Canada - Mon May 09, 3:00PM CDT
ST. LOUIS, MO --(Marketwired - May 09, 2016) -
SF: 34.79 (-0.65)

Stifel Welcomes ISM Team
Marketwired - Tue May 03, 3:30PM CDT
Stifel Financial Corp. (NYSE: SF) today announced that Stifel Nicolaus Europe Limited, its wholly-owned European broker-dealer, has closed the acquisition of ISM Capital LLP ("ISM", an independent investment bank focused on international debt capital markets. The acquisition of ISM adds significantly to Stifel's debt capital markets origination, sales and research capabilities in Europe, including an end-to-end platform for convertible securities and other equity-linked debt instruments.
SF: 34.79 (-0.65)

Stifel Financial Schedules First Quarter 2016 Financial Results Conference Call
GlobeNewswire - Mon May 02, 4:00PM CDT
Stifel Financial Corp. (NYSE:SF) will release its first quarter 2016 financial results after the market close on Monday, May 9, 2016. The company will host a conference call to review the results at 5:00 p.m. Eastern Time that same day. The conference call may include forward-looking statements.
SF: 34.79 (-0.65)

Stifel Appoints Two New Members to Board of Directors
Marketwired - Tue Apr 19, 3:30PM CDT
Stifel Financial Corp. (NYSE: SF) today announced that its board of directors has appointed two new members. Kathleen Brown and Maura A. Markus will join Stifel's board effective as of the firm's 2016 annual meeting. The two new independent directors will replace current independent directors Charles A. Dill and Alton F. Irby III, who have chosen to retire effective as of the annual meeting in accordance with Stifel's retirement age policies.
SF: 34.79 (-0.65)

Notice to Brokerage Firm Customers Who Purchased Linn Energy and Other Oil and Gas Investments - Silver Law Group and Law Firm of David R. Chase, P.A. Investigation
GlobeNewswire - Thu Apr 14, 3:27PM CDT
Silver Law Group and the Law Firm of David R. Chase, P.A. continue to investigate stockbrokers' and brokerage firms' unsuitable recommendations to purchase Linn Energy ("LINE" and other oil and gas investments, including master limited partnership (MLPs).
SF: 34.79 (-0.65)

KBW Announces 2015 Bank Honor Roll Award Winners
BusinessWire - Mon Apr 11, 8:00AM CDT
KBW, a full-service, boutique investment bank and broker-dealer that specializes in the financial services sector, and a wholly owned subsidiary of Stifel Financial Corp. (NYSE:SF), today named 18 U.S. banking institutions to its coveted "Bank Honor Roll" of superior performers.
SF: 34.79 (-0.65)

The Zacks Analyst Blog Highlights: Goldman Sachs Group, Morgan Stanley, Raymond James Financial and Stifel Financial
Zacks Equity Research - Zacks Investment Research - Fri Apr 08, 8:30AM CDT
The Zacks Analyst Blog Highlights: Goldman Sachs Group, Morgan Stanley, Raymond James Financial and Stifel Financial
SF: 34.79 (-0.65), GS: 149.36 (-0.53), RJF: 52.68 (-0.18), MS: 25.47 (-0.07)

Goldman Sachs and 3 Other Broker Stocks to Avoid
Zacks Equity Research - Zacks Investment Research - Thu Apr 07, 4:02PM CDT
Let's focus on the effect of a slowing domestic and global economy on market-related revenues of investment brokerage firms.
SF: 34.79 (-0.65), GS: 149.36 (-0.53), RJF: 52.68 (-0.18), MS: 25.47 (-0.07)

Eaton Partners Opens New Office In Chicago
PR Newswire - Tue Mar 29, 8:15AM CDT
Eaton Partners, one of the world's largest placement agents, announces the upcoming opening in April 2016 of its seventh global office location in Chicago. This new office - which joins Eaton Partners' current offices in Hong Kong, Houston, London, Rowayton, San Diego, and Shanghai - will help further develop Eaton Partners' global investor network and placement capabilities. Managing Director Christopher Maduri will lead the new location within the Stifel Financial Corporation's Chicago office space located at 70 W Madison Street.
SF: 34.79 (-0.65)

KBW Announces Index Rebalancing for First-Quarter 2016
BusinessWire - Fri Mar 11, 8:00PM CST
Keefe, Bruyette & Woods, Inc., a full-service, boutique investment bank and broker-dealer that specializes in the financial services sector, and a wholly owned subsidiary of Stifel Financial Corp. (NYSE: SF), announces the upcoming index rebalancing for first quarter of 2016.
NLY: 10.62 (-0.18), FMER: 21.82 (-0.03), SF: 34.79 (-0.65), WAL: 35.29 (-0.92)

Stifel Hires Three Senior Investment Bankers in Its Technology Group
Marketwired - Mon Mar 07, 6:00AM CST
Stifel Financial Corp. (NYSE: SF) today announced three senior hires in its Investment Banking Group. Richard Vieira has joined Stifel as a Vice Chairman in the Technology Group and will be based in Boston. In addition, Gurinder Sidhu, based in Boston, and Raymond Wu, based in San Francisco, joined the Technology Group as Directors. All three will focus on software and will complement Stifel's well-established Software and SaaS Group, which is led by Mark Baillie and Steve Foland.
SF: 34.79 (-0.65)

Stifel Emphasizes Equity in 2015 Named Executive Officer Compensation
Marketwired - Thu Mar 03, 6:01AM CST
Stifel Financial Corp. (NYSE: SF) today announced that the Compensation Committee of Stifel's Board of Directors (the "Committee" determined that the 2015 compensation of Stifel's five named executive officers ("executive officers" will consist primarily of equity.
SF: 34.79 (-0.65)

Downtrend Call Working As Stifel Financial Stock Falls 27.6% (SF)
Comtex SmarTrend(R) - Fri Feb 19, 9:37AM CST
SmarTrend identified a Downtrend for Stifel Financial (NYSE:SF) on December 11th, 2015 at $42.46. In approximately 2 months, Stifel Financial has returned 27.56% as of today's recent price of $30.75.
SF: 34.79 (-0.65)

Stifel's Public Finance Group Ranks No. 1 in 2015 Municipal Negotiated Issues
Marketwired - Wed Feb 10, 3:15PM CST
Stifel Financial Corp. (NYSE: SF) today announced that its Public Finance group, including acquired firms, led the nation in number of negotiated issues in 2015, serving as sole or senior manager for 811 transactions with a total par value of more than $16.7 billion, according to data from Thomson Reuters SDC.
SF: 34.79 (-0.65)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 13

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 14

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 14

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 15

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 14

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Telehealth Trends: A Comprehensive Yearly Insight

Updated Category News Views 346

FAIR Health's Telehealth Tracker: A Milestone Year FAIR Health has reached a significant milestone with its Monthly Telehealth Regional Tracker entering its sixth year. This tracker provides valuable insights into how telehealth usage has evolved, empowering stakeholders to understand trends in healthcare delivery. New Features and Data Insights The latest iteration of...

Continue Reading
Exploring Analog Devices: A $1000 Investment Journey

Updated Category News Views 139

The Growth of Analog Devices Inc (NASDAQ: ADI) Investors have increasingly turned their attention to Analog Devices Inc, a leader in the semiconductor industry. Over the last five years, Analog Devices has consistently outperformed the market, showcasing an annualized return of 16.0%. With a current market capitalization standing at an impressive $119.42 billion, the...

Continue Reading
Celebrating Excellence in Clinical Simulation: Meet the Nominees

Updated Category News Views 110

Highlighting Excellence in Clinical Simulation Awards A Representation of the Best in Simulation Healthcare Education in 2024 Education Management Solutions (EMS), a frontrunner in healthcare simulation and competency management platforms, has proudly announced its nominees for the 16th Annual Excellence in Clinical Simulation Awards. Each year, this noteworthy event...

Continue Reading
Significant Oil Price Drop Benefits Airlines and Cruise Lines

Updated Category News Views 195

Oil Prices Experience a Significant Drop Amid Easing Tensions Oil prices witnessed a noticeable decrease recently, plummeting over 5% during early trading in New York. This shift came as geopolitical tensions in the Middle East appeared to stabilize after an assurance from Israeli Prime Minister Benjamin Netanyahu that Iran’s oil facilities would not be targets in any...

Continue Reading
RxSight, Inc. Faces Legal Challenges: Investors Invited to Join Lawsuit

Updated Category News Views 136

RxSight, Inc. Investors Invited to Participate in Class Action Lawsuit Investors of RxSight, Inc. are becoming aware of significant opportunities to engage in a class action lawsuit. This legal action is being initiated by Bronstein, Gewirtz & Grossman, LLC, a law firm with a national reputation for advocating on behalf of investors. They are notifying shareholders that...

Continue Reading